USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor ...

Researchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Most policies impose a waiting period of 2-4 years for pre-existing diseases like diabetes, blood pressure, or thyroid issues. With the Instant Cover add-on, coverage for such conditions can begin ...

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the ...

For the medical team at the SIUE WE CARE Clinic in East St. Louis, the commitment to holistic, interdisciplinary care never ...

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

A Lancet study by the Global Burden of Disease project reveals non-communicable diseases like heart disease, stroke, and ...

CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

This powerful, 20-minute habit is the ultimate proof that you don't need to overhaul your life to achieve incredible health ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Lenvatinib plus pembrolizumab and chemotherapy did not significantly improve overall survival in metastatic ESCC compared to pembrolizumab and chemotherapy alone. Median overall survival was 17.6 ...